Tryg A/S
Group CEO Morten Hübbe has been granted 15,349 Tryg shares for a total amount of DKK 3,155,754 and Group COO Lars Bonde has been granted 7,481 Tryg shares for a total amount of DKK 1,538,094 related to the matching shares programme from 2017.
See attachment for further details.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Onco3R Therapeutics BV8.1.2026 09:00:00 CET | Press release
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics
Santhera Pharmaceuticals Holding AG8.1.2026 08:16:03 CET | Press release
Santhera Licenses AGAMREE® (Vamorolone) to Nxera Pharma in Japan, South Korea, Australia and New Zealand in a Deal Valued at up to USD 205 Million Plus Royalties
CMR Surgical8.1.2026 08:03:26 CET | Press release
CMR Surgical receives CE Mark for use of Versius in paediatric surgery
Sampo plc8.1.2026 07:30:00 CET | Press release
Sampo plc’s share buybacks 7 January 2026
Basilea Pharmaceutica AG, Allschwil8.1.2026 07:15:00 CET | Press release
Basilea provides portfolio update and outlook
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom